Source: News-Medical

genOway: ERS Genomics and genOway enter CRISPR/Cas9 agreement

ERS Genomics Limited today announced a non-exclusive license agreement granting genOway past and future access to ERS Genomics' CRISPR/Cas9 patent portfolio.

Read full article »
genOway's Competitors | genOway's News | genOway's Financials
Stay up-to-date with the latest news on genOway
Annual Revenue
$5.0-25M
Employees
100-250
Christian Grenier's photo - Chairman & CEO of genOway

Chairman & CEO

Christian Grenier

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on genOway